{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:43:14Z","timestamp":1787503394881,"version":"build-2736575974"},"reference-count":18,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"abstract":"<jats:p>Pulmonary arterial hypertension (PAH) associated with chronic lung disease of infancy can be a life-threatening disease affecting an increasing number of former premature infants. There is a need for improved delivery of targeted PAH therapies for this subgroup of patients who have severe and persistent PAH despite standard respiratory care for chronic lung disease. Currently infants who have severe PAH despite oral or inhaled therapy receive continuous intravenous prostanoid therapy (mostly epoprostenol), which is complicated because of the need for central venous access and associated catheter-related complications. We present a series of 5 infants who were successfully treated with a continuous infusion of subcutaneous treprostinil, which is a longer-acting prostanoid with similar hemodynamic effects. There were improvements in echocardiographic assessment of right ventricular function and estimated pulmonary hypertension, and in respiratory support required within weeks of therapy. Unlike commonly in adults, these 5 infants had no instances of severe site erythema, bleeding, bruising, or infection. In our experience with 5 former extremely preterm infants who had PAH associated with chronic lung disease, subcutaneous treprostinil was safe, efficacious, and well tolerated. We believe that subcutaneous treprostinil can be beneficial in a select group of former premature infants who have chronic lung disease and severe pulmonary arterial hypertension who have not responded adequately to conservative therapies.<\/jats:p>","DOI":"10.1542\/peds.2013-2330","type":"journal-article","created":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T10:45:34Z","timestamp":1404211534000},"page":"e274-e278","source":"Crossref","is-referenced-by-count":65,"title":["Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy"],"prefix":"10.1542","volume":"134","author":[{"given":"Dina J.","family":"Ferdman","sequence":"first","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika B.","family":"Rosenzweig","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren A.","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"issue":"17","key":"2021121107560273900_B1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2021121107560273900_B2"},{"issue":"6","key":"2021121107560273900_B3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1542\/peds.2007-0971","article-title":"Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.","volume":"120","author":"Khemani","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"2021121107560273900_B4","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00246-008-9260-x","article-title":"Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.","volume":"29","author":"Krishnan","year":"2008","journal-title":"Pediatr Cardiol"},{"issue":"6","key":"2021121107560273900_B5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","article-title":"Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil.","volume":"28","author":"Barst","year":"2006","journal-title":"Eur Respir J"},{"issue":"113","key":"2021121107560273900_B6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1183\/09059180.00003809","article-title":"The use of combination therapy in pulmonary arterial hypertension: new developments.","volume":"18","author":"Gali\u00e8","year":"2009","journal-title":"Eur Respir Rev"},{"issue":"9","key":"2021121107560273900_B7","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children.","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"issue":"7","key":"2021121107560273900_B8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2012.02.025","article-title":"Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.","volume":"31","author":"Sadushi-Koli\u00e7i","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"2021121107560273900_B9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1378\/chest.06-2118","article-title":"Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial.","volume":"132","author":"Rubenfire","year":"2007","journal-title":"Chest"},{"issue":"5","key":"2021121107560273900_B10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.healun.2013.01.1055","article-title":"Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics.","volume":"32","author":"Siehr","year":"2013","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"2021121107560273900_B11","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.healun.2010.06.013","article-title":"Subcutaneous treprostinil in pulmonary arterial hypertension: practical considerations.","volume":"29","author":"Mathier","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"2021121107560273900_B12","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jpeds.2010.09.025","article-title":"Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension.","volume":"158","author":"Levy","year":"2011","journal-title":"J Pediatr"},{"issue":"1","key":"2021121107560273900_B13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clp.2011.12.006","article-title":"Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.","volume":"39","author":"Porta","year":"2012","journal-title":"Clin Perinatol"},{"issue":"4","key":"2021121107560273900_B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.siny.2006.02.010","article-title":"Pain perception development and maturation.","volume":"11","author":"Simons","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"issue":"14","key":"2021121107560273900_B15","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1523\/JNEUROSCI.0348-06.2006","article-title":"Cortical pain responses in human infants.","volume":"26","author":"Slater","year":"2006","journal-title":"J Neurosci"},{"issue":"5","key":"2021121107560273900_B16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1542\/peds.98.5.925","article-title":"Experience in a neonatal intensive care unit affects pain response.","volume":"98","author":"Johnston","year":"1996","journal-title":"Pediatrics"},{"issue":"9","key":"2021121107560273900_B17","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/79658","article-title":"Pain, plasticity, and premature birth: a prescription for permanent suffering?","volume":"6","author":"Anand","year":"2000","journal-title":"Nat Med"},{"issue":"1","key":"2021121107560273900_B18","doi-asserted-by":"crossref","first-page":"F15","DOI":"10.1136\/fetalneonatal-2011-301572","article-title":"Babies born at the threshold of viability: changes in survival and workload over 20 years.","volume":"98","author":"Seaton","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/1\/e274\/1058194\/peds_2013-2330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/1\/e274\/1058194\/peds_2013-2330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T04:15:08Z","timestamp":1639196108000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/1\/e274\/62272\/Subcutaneous-Treprostinil-for-Pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,7,1]]},"published-print":{"date-parts":[[2014,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-2330","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}